Le Beau MM - Search Results

1

Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.

Godley LA, Njiaju UO, Green M, Weiner H, Lin S, Odenike O, Rich ES, Artz A, Van Besien K, Daugherty CK, Zhang Y, Le Beau MM, Stock W, Larson RA. Godley LA, et al. Among authors: le beau mm. Leuk Lymphoma. 2010 Jun;51(6):995-1006. doi: 10.3109/10428191003763468. Leuk Lymphoma. 2010. PMID: 20536346 Clinical Trial.

2

Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.

Larson RA, Le Beau MM. Larson RA, et al. Among authors: le beau mm. Chem Biol Interact. 2005 May 30;153-154:187-95. doi: 10.1016/j.cbi.2005.03.023. Epub 2005 Apr 13. Chem Biol Interact. 2005. PMID: 15935816

3

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.

Cahill KE, Karimi YH, Karrison TG, Jain N, Green M, Weiner H, Fulton N, Kadri S, Godley LA, Artz AS, Liu H, Thirman MJ, Le Beau MM, McNerney ME, Segal J, Larson RA, Stock W, Odenike O. Cahill KE, et al. Among authors: le beau mm. Blood Adv. 2020 Feb 25;4(4):599-606. doi: 10.1182/bloodadvances.2019000795. Blood Adv. 2020. PMID: 32074275 Free PMC article. Clinical Trial.

4

Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.

Patel AA, Rojek AE, Drazer MW, Weiner H, Godley LA, Le Beau MM, Larson RA. Patel AA, et al. Among authors: le beau mm. Blood Adv. 2021 Oct 26;5(20):4140-4148. doi: 10.1182/bloodadvances.2021004964. Blood Adv. 2021. PMID: 34492705 Free PMC article.

5

Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. Qian Z, et al. Among authors: le beau mm. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14925-30. doi: 10.1073/pnas.222491799. Epub 2002 Nov 4. Proc Natl Acad Sci U S A. 2002. PMID: 12417757 Free PMC article.

6

Kebriaei P, Winter JN, Laport GG, Le Beau MM, Dewald G, Larson RA. Kebriaei P, et al. Among authors: le beau mm. Leuk Res. 2004 May;28(5):537-40. doi: 10.1016/j.leukres.2003.09.010. Leuk Res. 2004. PMID: 15068908

7

Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.

Qian Z, Joslin JM, Tennant TR, Reshmi SC, Young DJ, Stoddart A, Larson RA, Le Beau MM. Qian Z, et al. Among authors: le beau mm. Chem Biol Interact. 2010 Mar 19;184(1-2):50-7. doi: 10.1016/j.cbi.2009.11.025. Epub 2009 Dec 1. Chem Biol Interact. 2010. PMID: 19958752 Free PMC article. Review.

8

An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.

Godley LA, Cunningham J, Dolan ME, Huang RS, Gurbuxani S, McNerney ME, Larson RA, Leong H, Lussier Y, Onel K, Odenike O, Stock W, White KP, Le Beau MM. Godley LA, et al. Among authors: le beau mm. Semin Oncol. 2011 Apr;38(2):215-24. doi: 10.1053/j.seminoncol.2011.01.003. Semin Oncol. 2011. PMID: 21421111 Free PMC article. Review.

9

Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy-related myeloid neoplasm.

Larson RA, Le Beau MM. Larson RA, et al. Among authors: le beau mm. Mediterr J Hematol Infect Dis. 2011;3(1):e2011032. doi: 10.4084/MJHID.2011.032. Epub 2011 Jul 8. Mediterr J Hematol Infect Dis. 2011. PMID: 21869918 Free PMC article.

10

The histone code and treatments for acute myeloid leukemia.

Godley LA, Le Beau MM. Godley LA, et al. Among authors: le beau mm. N Engl J Med. 2012 Mar 8;366(10):960-1. doi: 10.1056/NEJMcibr1113401. N Engl J Med. 2012. PMID: 22397660 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters